newGenia has highly experienced leaders in their respective fields. The ambition is to bring faster, secure and modular genomic analysis services to everyone

Dr. Sabeen Asad Khan
An experienced clinician turned system biologist.
MD (Hamdard Medical University, Pakistan)
M.Sc. Systems Biology (University of Skövde, Sweden)

Shahan Khan
Experienced in research and development and business strategy.
M.Sc. Software Engineering (Blekinge Tekniska Högskola, Sweden)
MBA Marketing

Dr. C. Alexander Valencia
Experienced in setting genomic data analysis research and development teams in leading businesses.
Ph.D. in Biochemistry/Molecular Biology (Carleton University, University of Ottawa, USA)
Postdoctoral researcher School of Pharmacy and Carolina Center for Genome Sciences (University of North Carolina at Chapel Hill, USA)
Fellowship researcher Department of Human Genetics (Emory University School of Medicine, USA)

Ikhlaq Ahmad
With extensive experience in large to medium-sized data-driven organizations, Ikhlaq has developed a proven expertise in designing and implementing high-performance, secure systems tailored to meet complex business needs.

Tatiana Piskunova
Tatiana is a highly skilled and versatile product developer with a wealth of experience across diverse industries, including finance, bioinformatics, healthcare, pharmacovigilance, and oil and gas. Her extensive background in managing complex data and projects makes her an ideal Technical Product Owner. Driven by a passion for delivering exceptional value to users, Tatiana excels at designing innovative solutions that navigate complex regulatory landscapes, large-scale data processing challenges, and the needs of multiple stakeholders.

Sri Harsha Meghadri
Harsha is a highly skilled bioinformatics and molecular biology professional with a robust background in genomics, specializing in transcriptomics, NGS analysis, and clinical applications. With over 9 years of international experience across leading research laboratories in Germany, Sweden, and India, Harsha has developed deep expertise in drug repurposing, metagenomics, and the development of sequencing-based assays. His work consistently bridges cutting-edge research with practical, impactful solutions in the life sciences.